TreeWAS – Variant ID: rs2488856

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.171	0.829	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.171	0.829	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.170	0.830	0.000
T39.1 4-Aminophenol derivatives	0.164	0.836	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.162	0.838	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.161	0.839	0.000
T42.4 Benzodiazepines	0.153	0.847	0.000
T39.0 Salicylates	0.148	0.852	0.000
T43.2 Other and unspecified antidepressants	0.147	0.853	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.147	0.853	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.145	0.854	0.000
T42.1 Iminostilbenes	0.140	0.860	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.139	0.861	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.135	0.865	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.133	0.867	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.132	0.868	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.132	0.868	0.000
T42.3 Barbiturates	0.131	0.869	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.130	0.869	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.129	0.871	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.129	0.871	0.000
T43.6 Psychostimulants with abuse potential	0.128	0.872	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.127	0.873	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.125	0.875	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.124	0.876	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.123	0.877	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.122	0.877	0.000
T42.2 Succinimides and oxazolidinediones	0.122	0.877	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.122	0.878	0.000
T39.4 Antirheumatics, not elsewhere classified	0.122	0.878	0.000
T39.2 Pyrazolone derivatives	0.122	0.878	0.000
T36 Poisoning by systemic antibiotics	0.121	0.879	0.000
T45.0 Antiallergic and antiemetic drugs	0.119	0.881	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.119	0.881	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.116	0.884	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.115	0.885	0.000
T42.0 Hydantoin derivatives	0.114	0.886	0.000
T43.9 Psychotropic drug, unspecified	0.114	0.886	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.109	0.891	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.107	0.893	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.106	0.894	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.106	0.894	0.000
T46.1 Calcium-channel blockers	0.105	0.895	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.104	0.895	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.104	0.895	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.104	0.895	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.104	0.895	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.104	0.895	0.000
T44.0 Anticholinesterase agents	0.104	0.895	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.104	0.896	0.000
T45.5 Anticoagulants	0.104	0.896	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.103	0.897	0.000
T40.2 Other opioids	0.102	0.898	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.100	0.900	0.000
T45.8 Other primarily systemic and haematological agents	0.100	0.900	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.100	0.900	0.000
T45.6 Fibrinolysis-affecting drugs	0.100	0.900	0.000
T45.3 Enzymes, not elsewhere classified	0.100	0.900	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.098	0.902	0.000
T47.6 Antidiarrhoeal drugs	0.097	0.903	0.000
T45.2 Vitamins, not elsewhere classified	0.097	0.903	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.096	0.903	0.000
T47.0 Histamine H(2)-receptor antagonists	0.096	0.904	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.095	0.905	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.095	0.905	0.000
T47.7 Emetics	0.095	0.905	0.000
T47.5 Digestants	0.095	0.905	0.000
T47.3 Saline and osmotic laxatives	0.095	0.905	0.000
T47.4 Other laxatives	0.095	0.905	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.094	0.905	0.000
T48.4 Expectorants	0.094	0.905	0.000
T48.3 Antitussives	0.094	0.905	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.094	0.905	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.094	0.905	0.000
T48.0 Oxytocic drugs	0.094	0.905	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.094	0.906	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.094	0.906	0.000
T48.5 Anti-common-cold drugs	0.094	0.906	0.000
T45.4 Iron and its compounds	0.092	0.908	0.000
T36.8 Other systemic antibiotics	0.092	0.908	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.091	0.909	0.000
T47.2 Stimulant laxatives	0.091	0.909	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.091	0.909	0.000
T37.5 Antiviral drugs	0.091	0.909	0.000
T37.4 Anthelminthics	0.091	0.909	0.000
T37.3 Other antiprotozoal drugs	0.091	0.909	0.000
T37.1 Antimycobacterial drugs	0.091	0.909	0.000
T37.0 Sulphonamides	0.091	0.909	0.000
T36.3 Macrolides	0.090	0.909	0.000
T36.4 Tetracyclines	0.090	0.910	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.090	0.910	0.000
T46.7 Peripheral vasodilators	0.090	0.910	0.000
T41.2 Other and unspecified general anaesthetics	0.089	0.911	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.089	0.911	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.089	0.911	0.000
T41.5 Therapeutic gases	0.089	0.911	0.000
T41.4 Anaesthetic, unspecified	0.089	0.911	0.000
T41.3 Local anaesthetics	0.089	0.911	0.000
T41.1 Intravenous anaesthetics	0.089	0.911	0.000
T41.0 Inhaled anaesthetics	0.089	0.911	0.000
T49.9 Topical agent, unspecified	0.088	0.912	0.000
T49.8 Other topical agents	0.088	0.912	0.000
T49.7 Dental drugs, topically applied	0.088	0.912	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.088	0.912	0.000
T49.5 Ophthalmological drugs and preparations	0.088	0.912	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.088	0.912	0.000
T49.3 Emollients, demulcents and protectants	0.088	0.912	0.000
T49.2 Local astringents and local detergents	0.088	0.912	0.000
T49.1 Antipruritics	0.088	0.912	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.088	0.912	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.088	0.912	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.088	0.912	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.087	0.912	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.087	0.913	0.000
T36.9 Systemic antibiotic, unspecified	0.087	0.913	0.000
T36.7 Antifungal antibiotics, systemically used	0.087	0.913	0.000
T36.6 Rifamycins	0.087	0.913	0.000
T36.5 Aminoglycosides	0.087	0.913	0.000
T36.2 Chloramphenicol group	0.087	0.913	0.000
T40.1 Heroin	0.085	0.915	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.084	0.915	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.083	0.917	0.000
T40.8 Lysergide [LSD]	0.083	0.917	0.000
T40.7 Cannabis (derivatives)	0.083	0.917	0.000
T40.0 Opium	0.083	0.917	0.000
T40.3 Methadone	0.080	0.920	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.079	0.920	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.078	0.922	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.076	0.924	0.000
T38.0 Glucocorticoids and synthetic analogues	0.075	0.925	0.000
T38.5 Other oestrogens and progestogens	0.075	0.925	0.000
T38.9 Other and unspecified hormone antagonists	0.074	0.926	0.000
T38.7 Androgens and anabolic congeners	0.074	0.926	0.000
T38.4 Oral contraceptives	0.074	0.926	0.000
T38.2 Antithyroid drugs	0.074	0.926	0.000
T40.5 Cocaine	0.073	0.926	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.071	0.929	0.000
T36.0 Penicillins	0.070	0.930	0.000
T38.1 Thyroid hormones and substitutes	0.069	0.931	0.000
T40.6 Other and unspecified narcotics	0.068	0.931	0.000
T50.8 Diagnostic agents	0.065	0.934	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.064	0.935	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.064	0.936	0.000
T50.7 Analeptics and opioid receptor antagonists	0.063	0.937	0.000
T50.5 Appetite depressants	0.063	0.937	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.063	0.937	0.000
T50.0 Mineralocorticoids and their antagonists	0.063	0.937	0.000
T50.1 Loop [high-ceiling] diuretics	0.061	0.939	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.060	0.940	0.000
T40.4 Other synthetic narcotics	0.059	0.941	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.058	0.942	0.000
T50.4 Drugs affecting uric acid metabolism	0.058	0.942	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.036	0.964	0.000
Z09.0 Follow-up examination after surgery for other conditions	0.000	0.976	0.024
M47.86 Other spondylosis (Lumbar region)	0.000	0.982	0.018
I31.3 Pericardial effusion (noninflammatory)	0.017	0.983	0.000
J33.9 Nasal polyp, unspecified	0.000	0.986	0.014
I31 Other diseases of pericardium	0.014	0.986	0.000
I31.9 Disease of pericardium, unspecified	0.013	0.987	0.000
J32 Chronic sinusitis	0.000	0.988	0.012
J32.2 Chronic ethmoidal sinusitis	0.000	0.988	0.012
M47.8 Other spondylosis	0.000	0.989	0.011
J32.9 Chronic sinusitis, unspecified	0.000	0.989	0.011
I31.1 Chronic constrictive pericarditis	0.010	0.989	0.000
M47.89 Other spondylosis (Site unspecified)	0.000	0.989	0.011
J32.4 Chronic pansinusitis	0.000	0.990	0.010
J33 Nasal polyp	0.000	0.990	0.010
J31.0 Chronic rhinitis	0.000	0.990	0.010
J30-J39 Other diseases of upper respiratory tract	0.000	0.990	0.010
I31.8 Other specified diseases of pericardium	0.010	0.990	0.000
I31.2 Haemopericardium, not elsewhere classified	0.010	0.990	0.000
J32.1 Chronic frontal sinusitis	0.000	0.990	0.010
I31.0 Chronic adhesive pericarditis	0.010	0.990	0.000
M47.82 Other spondylosis (Cervical region)	0.000	0.990	0.010
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.990	0.010
J32.0 Chronic maxillary sinusitis	0.000	0.990	0.010
M47.84 Other spondylosis (Thoracic region)	0.000	0.991	0.009
M48.06 Spinal stenosis (Lumbar region)	0.000	0.991	0.009
J34.3 Hypertrophy of nasal turbinates	0.000	0.991	0.009
J32.3 Chronic sphenoidal sinusitis	0.000	0.991	0.009
J32.8 Other chronic sinusitis	0.000	0.991	0.009
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.000	0.992	0.008
J34 Other disorders of nose and nasal sinuses	0.000	0.992	0.008
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.000	0.992	0.008
M47.85 Other spondylosis (Thoracolumbar region)	0.000	0.992	0.008
J37 Chronic laryngitis and laryngotracheitis	0.000	0.992	0.008
J35.0 Chronic tonsillitis	0.000	0.992	0.008
J35 Chronic diseases of tonsils and adenoids	0.000	0.992	0.008
M47.83 Other spondylosis (Cervicothoracic region)	0.000	0.992	0.008
J36 Peritonsillar abscess	0.000	0.992	0.008
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.992	0.008
R16.1 Splenomegaly, not elsewhere classified	0.000	0.992	0.008
M47.80 Other spondylosis (Multiple sites in spine)	0.000	0.993	0.007
J33.1 Polypoid sinus degeneration	0.000	0.993	0.007
J31.1 Chronic nasopharyngitis	0.000	0.993	0.007
J33.8 Other polyp of sinus	0.000	0.993	0.007
J37.0 Chronic laryngitis	0.000	0.993	0.007
J35.1 Hypertrophy of tonsils	0.000	0.993	0.007
J35.2 Hypertrophy of adenoids	0.000	0.993	0.007
J34.1 Cyst and mucocele of nose and nasal sinus	0.000	0.993	0.007
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.994	0.006
J37.1 Chronic laryngotracheitis	0.000	0.994	0.006
J30 Vasomotor and allergic rhinitis	0.000	0.994	0.006
J31.2 Chronic pharyngitis	0.000	0.994	0.006
J30.4 Allergic rhinitis, unspecified	0.000	0.994	0.006
J39 Other diseases of upper respiratory tract	0.000	0.994	0.006
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.995	0.005
M47.87 Other spondylosis (Lumbosacral region)	0.000	0.995	0.005
T51.0 Ethanol	0.005	0.995	0.000
J30.2 Other seasonal allergic rhinitis	0.000	0.995	0.005
J30.0 Vasomotor rhinitis	0.000	0.995	0.005
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.995	0.004
Z96.0 Presence of urogenital implants	0.000	0.995	0.005
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.995	0.004
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.996	0.004
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.996	0.004
J39.1 Other abscess of pharynx	0.000	0.996	0.004
B07 Viral warts	0.004	0.996	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.000	0.996	0.004
J39.8 Other specified diseases of upper respiratory tract	0.000	0.996	0.004
M48.0 Spinal stenosis	0.000	0.996	0.004
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.997	0.003
J30.3 Other allergic rhinitis	0.000	0.997	0.003
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.997	0.003
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.997	0.003
T51 Toxic effect of alcohol	0.003	0.997	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.997	0.003
J34.2 Deviated nasal septum	0.000	0.997	0.003
N30.2 Other chronic cystitis	0.000	0.997	0.003
E87.2 Acidosis	0.003	0.997	0.000
J39.2 Other diseases of pharynx	0.000	0.997	0.003
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.997	0.003
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.997	0.003
J30.1 Allergic rhinitis due to pollen	0.000	0.997	0.003
B02 Zoster [herpes zoster]	0.003	0.997	0.000
M48.04 Spinal stenosis (Thoracic region)	0.000	0.997	0.003
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.997	0.003
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.003	0.997	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.997	0.003
J33.0 Polyp of nasal cavity	0.000	0.997	0.003
E27.1 Primary adrenocortical insufficiency	0.000	0.997	0.003
B02.3 Zoster ocular disease	0.003	0.997	0.000
B02.8 Zoster with other complications	0.002	0.997	0.000
N28.8 Other specified disorders of kidney and ureter	0.003	0.997	0.000
B02.2 Zoster with other nervous system involvement	0.002	0.997	0.000
M79.08 Rheumatism, unspecified (Other)	0.000	0.997	0.002
T51.8 Other alcohols	0.002	0.997	0.000
T51.3 Fusel oil	0.002	0.997	0.000
T51.2 2-Propanol	0.002	0.997	0.000
T51.1 Methanol	0.002	0.997	0.000
B02.1 Zoster meningitis	0.002	0.998	0.000
M85.8 Other specified disorders of bone density and structure	0.000	0.998	0.002
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.000	0.998	0.002
M85.80 Other specified disorders of bone density and structure (Multiple sites)	0.000	0.998	0.002
E27 Other disorders of adrenal gland	0.000	0.998	0.002
M79.0 Rheumatism, unspecified	0.000	0.998	0.002
Q50.4 Embryonic cyst of Fallopian tube	0.002	0.998	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.002
M48.02 Spinal stenosis (Cervical region)	0.000	0.998	0.002
B02.7 Disseminated zoster	0.002	0.998	0.000
B02.0 Zoster encephalitis	0.002	0.998	0.000
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.000	0.998	0.002
B00 Herpesviral [herpes simplex] infections	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.002	0.998	0.000
B06 Rubella [German measles]	0.002	0.998	0.000
B05 Measles	0.002	0.998	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.002	0.998	0.000
B04 Monkeypox	0.002	0.998	0.000
B03 Smallpox	0.002	0.998	0.000
B02.9 Zoster without complication	0.002	0.998	0.000
K65.9 Peritonitis, unspecified	0.000	0.998	0.002
S70.9 Superficial injury of hip and thigh, unspecified	0.002	0.998	0.000
S92.10 Fracture of talus (closed)	0.000	0.998	0.002
Q65.8 Other congenital deformities of hip	0.002	0.998	0.000
M85.88 Other specified disorders of bone density and structure (Other)	0.000	0.998	0.002
H53.4 Visual field defects	0.000	0.998	0.002
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.998	0.002
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.998	0.002
Z09.2 Follow-up examination after chemotherapy for other conditions	0.000	0.998	0.002
M48.09 Spinal stenosis (Site unspecified)	0.000	0.998	0.002
N30.3 Trigonitis	0.000	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.002	0.998	0.000
V23.4 Driver injured in traffic accident	0.000	0.998	0.002
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.002	0.998	0.000
B01 Varicella [chickenpox]	0.002	0.998	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.000	0.998	0.002
E27.9 Disorder of adrenal gland, unspecified	0.000	0.998	0.002
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.998	0.002
E27.2 Addisonian crisis	0.000	0.998	0.002
B00.8 Other forms of herpesviral infection	0.002	0.998	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
M19.94 Arthrosis, unspecified (Hand)	0.002	0.998	0.000
M85.84 Other specified disorders of bone density and structure (Hand)	0.000	0.998	0.002
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
E34.9 Endocrine disorder, unspecified	0.000	0.998	0.002
I34.0 Mitral (valve) insufficiency	0.002	0.998	0.000
M47 Spondylosis	0.000	0.998	0.002
M85.87 Other specified disorders of bone density and structure (Ankle and foot)	0.000	0.998	0.002
M85.83 Other specified disorders of bone density and structure (Forearm)	0.000	0.998	0.002
I34.1 Mitral (valve) prolapse	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.998	0.002
E27.0 Other adrenocortical overactivity	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.002
I34 Nonrheumatic mitral valve disorders	0.002	0.998	0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M79.04 Rheumatism, unspecified (Hand)	0.000	0.998	0.002
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.998	0.002
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.998	0.002
Z09.1 Follow-up examination after radiotherapy for other conditions	0.000	0.998	0.002
B00.5 Herpesviral ocular disease	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
I45.8 Other specified conduction disorders	0.002	0.998	0.000
I50.0 Congestive heart failure	0.002	0.998	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
I44.7 Left bundle-branch block, unspecified	0.002	0.998	0.000
T63.4 Venom of other arthropods	0.002	0.998	0.000
Z09.3 Follow-up examination after psychotherapy	0.000	0.998	0.002
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.000	0.998	0.002
T63 Toxic effect of contact with venomous animals	0.002	0.998	0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.000	0.998	0.002
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.000	0.998	0.002
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.998	0.002
B01.8 Varicella with other complications	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.002
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.002
B05.9 Measles without complication	0.002	0.998	0.000
B05.8 Measles with other complications	0.002	0.998	0.000
B05.4 Measles with intestinal complications	0.002	0.998	0.000
B05.3 Measles complicated by otitis media	0.002	0.998	0.000
B05.2 Measles complicated by pneumonia	0.002	0.998	0.000
B05.1 Measles complicated by meningitis	0.002	0.998	0.000
B05.0 Measles complicated by encephalitis	0.002	0.998	0.000
B06.9 Rubella without complication	0.002	0.998	0.000
B06.8 Rubella with other complications	0.002	0.998	0.000
B06.0 Rubella with neurological complications	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
Q65 Congenital deformities of hip	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.998	0.002
E24.0 Pituitary-dependent Cushing's disease	0.000	0.998	0.002
E34 Other endocrine disorders	0.000	0.998	0.002
E24 Cushing's syndrome	0.000	0.998	0.002
I50 Heart failure	0.002	0.998	0.000
Z09.4 Follow-up examination after treatment of fracture	0.000	0.998	0.002
I30 Acute pericarditis	0.002	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.998	0.002
Q24 Other congenital malformations of heart	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.000	0.998	0.002
B01.1 Varicella encephalitis	0.002	0.998	0.000
B01.0 Varicella meningitis	0.002	0.998	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.002	0.998	0.000
B08.5 Enteroviral vesicular pharyngitis	0.002	0.998	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.002	0.998	0.000
B08.3 Erythema infectiosum [fifth disease]	0.002	0.998	0.000
B08.2 Exanthema subitum [sixth disease]	0.002	0.998	0.000
B08.0 Other orthopoxvirus infections	0.002	0.998	0.000
M48 Other spondylopathies	0.000	0.998	0.002
B01.2 Varicella pneumonia	0.002	0.998	0.000
S70 Superficial injury of hip and thigh	0.002	0.998	0.000
I30-I52 Other forms of heart disease	0.002	0.998	0.000
T62 Toxic effect of other noxious substances eaten as food	0.002	0.998	0.000
T58 Toxic effect of carbon monoxide	0.002	0.998	0.000
S70.1 Contusion of thigh	0.002	0.998	0.000
I45 Other conduction disorders	0.002	0.998	0.000
T55 Toxic effect of soaps and detergents	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
I34.8 Other nonrheumatic mitral valve disorders	0.002	0.998	0.000
M47.0 Anterior spinal and vertebral artery compression syndromes	0.000	0.998	0.002
E23 Hypofunction and other disorders of pituitary gland	0.000	0.998	0.002
T61 Toxic effect of noxious substances eaten as seafood	0.002	0.998	0.000
T54 Toxic effect of corrosive substances	0.002	0.998	0.000
D73.0 Hyposplenism	0.000	0.998	0.002
Q65.1 Congenital dislocation of hip, bilateral	0.002	0.998	0.000
C44.7 Skin of lower limb, including hip	0.000	0.998	0.002
E24.9 Cushing's syndrome, unspecified	0.000	0.998	0.002
Q24.0 Dextrocardia	0.002	0.998	0.000
Q65.9 Congenital deformity of hip, unspecified	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.998	0.002
B08.1 Molluscum contagiosum	0.001	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.998	0.002
Q65.2 Congenital dislocation of hip, unspecified	0.002	0.998	0.000
S70.8 Other superficial injuries of hip and thigh	0.002	0.998	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.002	0.998	0.000
Z90.2 Acquired absence of lung [part of]	0.000	0.998	0.002
E31 Polyglandular dysfunction	0.000	0.998	0.002
R14 Flatulence and related conditions	0.000	0.998	0.002
T60 Toxic effect of pesticides	0.002	0.998	0.000
T57 Toxic effect of other inorganic substances	0.002	0.998	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.002	0.998	0.000
T52 Toxic effect of organic solvents	0.002	0.998	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.000	0.998	0.002
I05.0 Mitral stenosis	0.000	0.998	0.002
M47.1 Other spondylosis with myelopathy	0.000	0.998	0.002
Q24.8 Other specified congenital malformations of heart	0.002	0.998	0.000
T63.8 Toxic effect of contact with other venomous animals	0.001	0.998	0.000
T63.6 Toxic effect of contact with other marine animals	0.001	0.998	0.000
T63.5 Toxic effect of contact with fish	0.001	0.998	0.000
T63.3 Venom of spider	0.001	0.998	0.000
T63.2 Venom of scorpion	0.001	0.998	0.000
T63.1 Venom of other reptiles	0.001	0.998	0.000
T63.0 Snake venom	0.001	0.998	0.000
E26 Hyperaldosteronism	0.000	0.998	0.002
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.002	0.998	0.000
I45.6 Preexcitation syndrome	0.002	0.998	0.000
Q24.6 Congenital heart block	0.002	0.998	0.000
Q65.6 Unstable hip	0.001	0.998	0.000
Q65.5 Congenital subluxation of hip, unspecified	0.001	0.998	0.000
Q65.4 Congenital subluxation of hip, bilateral	0.001	0.998	0.000
Q65.3 Congenital subluxation of hip, unilateral	0.001	0.998	0.000
Q65.0 Congenital dislocation of hip, unilateral	0.001	0.998	0.000
I43 Cardiomyopathy in diseases classified elsewhere	0.002	0.998	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
B00.9 Herpesviral infection, unspecified	0.001	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.998	0.001
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.998	0.001
E24.3 Ectopic ACTH syndrome	0.000	0.998	0.001
E24.1 Nelson's syndrome	0.000	0.998	0.001
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.001	0.998	0.000
Q50.5 Embryonic cyst of broad ligament	0.001	0.998	0.000
Q50.3 Other congenital malformations of ovary	0.001	0.998	0.000
Q50.2 Congenital torsion of ovary	0.001	0.998	0.000
Q50.1 Developmental ovarian cyst	0.001	0.998	0.000
Z09.7 Follow-up examination after combined treatment for other conditions	0.000	0.998	0.001
B00.4 Herpesviral encephalitis	0.001	0.998	0.000
E24.8 Other Cushing's syndrome	0.000	0.998	0.001
E34.5 Androgen resistance syndrome	0.000	0.998	0.001
E34.4 Constitutional tall stature	0.000	0.998	0.001
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.998	0.001
E34.1 Other hypersecretion of intestinal hormones	0.000	0.998	0.001
I30.0 Acute nonspecific idiopathic pericarditis	0.001	0.998	0.000
I45.5 Other specified heart block	0.002	0.998	0.000
I45.0 Right fascicular block	0.002	0.998	0.000
S92.1 Fracture of talus	0.000	0.998	0.002
T62.9 Noxious substance eaten as food, unspecified	0.001	0.998	0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.000	0.998	0.002
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.998	0.001
E30 Disorders of puberty, not elsewhere classified	0.000	0.998	0.001
I40 Acute myocarditis	0.002	0.998	0.000
I37 Pulmonary valve disorders	0.002	0.998	0.000
T56 Toxic effect of metals	0.001	0.998	0.000
B01.9 Varicella without complications	0.001	0.998	0.000
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.998	0.002
E21.2 Other hyperparathyroidism	0.000	0.998	0.001
E24.2 Drug-induced Cushing's syndrome	0.000	0.998	0.001
I45.9 Conduction disorder, unspecified	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.001	0.998	0.000
Q24.2 Cor triatriatum	0.001	0.998	0.000
Q24.1 Levocardia	0.001	0.998	0.000
Z60.2 Living alone	0.002	0.998	0.000
E32 Diseases of thymus	0.000	0.998	0.001
E25 Adrenogenital disorders	0.000	0.998	0.001
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.002
I43.1 Cardiomyopathy in metabolic diseases	0.001	0.998	0.000
M48.4 Fatigue fracture of vertebra	0.000	0.998	0.001
M48.3 Traumatic spondylopathy	0.000	0.998	0.001
M48.2 Kissing spine	0.000	0.998	0.001
M48.1 Ankylosing hyperostosis [Forestier]	0.000	0.998	0.001
Q50.0 Congenital absence of ovary	0.001	0.998	0.000
S79.9 Unspecified injury of hip and thigh	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.000	0.998	0.001
I30.8 Other forms of acute pericarditis	0.001	0.998	0.000
Q24.5 Malformation of coronary vessels	0.001	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.001	0.998	0.000
T61.2 Other fish and shellfish poisoning	0.001	0.998	0.000
T65 Toxic effect of other and unspecified substances	0.001	0.998	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.000	0.998	0.001
E26.0 Primary hyperaldosteronism	0.000	0.998	0.001
E31.0 Autoimmune polyglandular failure	0.000	0.998	0.001
I37.1 Pulmonary valve insufficiency	0.001	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.002	0.998	0.000
T54.9 Corrosive substance, unspecified	0.001	0.998	0.000
Q50-Q56 Congenital malformations of genital organs	0.002	0.998	0.000
S22.30 Fracture of rib (closed)	0.000	0.998	0.002
I45.4 Nonspecific intraventricular block	0.001	0.998	0.000
M48.9 Spondylopathy, unspecified	0.000	0.998	0.001
S70.7 Multiple superficial injuries of hip and thigh	0.001	0.998	0.000
T62.8 Other specified noxious substances eaten as food	0.001	0.998	0.000
T62.2 Other ingested (parts of) plant(s)	0.001	0.998	0.000
T62.1 Ingested berries	0.001	0.998	0.000
T62.0 Ingested mushrooms	0.001	0.998	0.000
E20 Hypoparathyroidism	0.000	0.998	0.001
I52 Other heart disorders in diseases classified elsewhere	0.001	0.998	0.000
I48 Atrial fibrillation and flutter	0.001	0.998	0.000
I41 Myocarditis in diseases classified elsewhere	0.001	0.998	0.000
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.001	0.998	0.000
I32 Pericarditis in diseases classified elsewhere	0.001	0.998	0.000
Q53 Undescended testicle	0.001	0.998	0.000
T59 Toxic effect of other gases, fumes and vapours	0.001	0.998	0.000
I30.1 Infective pericarditis	0.001	0.998	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.001	0.998	0.000
I51.9 Heart disease, unspecified	0.002	0.998	0.000
M48.8 Other specified spondylopathies	0.000	0.998	0.001
Q51.3 Bicornate uterus	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations